$8.370
-0.262 (-3.13%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KYTX Prediction & Forecast by Similar Chart Analysis
Alphio's KYTX stock price prediction model matches the current Kyverna Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.36 (-0.08%). The 1-week path is $8.45 (+1.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Kyverna Therapeutics Inc Stock?
Kyverna Therapeutics Inc is a good buy right now due to its potential for significant growth driven by the upcoming launch of miv-cel for Stiff-Person Syndrome, which analysts estimate could generate peak sales of $800 million. The current price of $8.37 is well below the analyst price targets of $25 and $29, indicating substantial upside potential. However, the company has reported consistent net losses, with a net income of -$39.7 million in Q1 2026, which poses a risk to investors.
KYTX stock price ended at $8.37 on Friday, after losing -3.13%
Kyverna Therapeutics Inc (KYTX) last closed at $8.37, losing -3.13%. These facts feed the 1-day and 1-week KYTX price prediction above.
Forecast Drivers
Kyverna Therapeutics Inc (KYTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches KYTX, ranked by similarity.
Seasonality analysis for KYTX
Historically the probability of a positive August return for KYTX is 4.76%. December offers the highest probability of a positive month at 51.16%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KYTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $4.04 | $4.71 | $4.73 | -43.74% |
| Sep 2026 | $4.19 | $4.70 | $5.00 | -43.86% |
| Oct 2026 | $3.24 | $3.80 | $4.02 | -54.63% |
| Nov 2026 | $3.51 | $4.26 | $4.92 | -49.08% |
| Dec 2026 | $3.43 | $3.52 | $4.24 | -57.99% |
In 2026, Kyverna Therapeutics Inc (KYTX) is projected to range from $3.24 to $5.00.
Kyverna Therapeutics Inc 2026 monthly forecast
In Aug 2026, Kyverna Therapeutics Inc is projected to average $4.71, with a low of $4.04 and high of $4.73.
In Sep 2026, Kyverna Therapeutics Inc is projected to average $4.70, with a low of $4.19 and high of $5.00.
In Oct 2026, Kyverna Therapeutics Inc is projected to average $3.80, with a low of $3.24 and high of $4.02.
In Nov 2026, Kyverna Therapeutics Inc is projected to average $4.26, with a low of $3.51 and high of $4.92.
In Dec 2026, Kyverna Therapeutics Inc is projected to average $3.52, with a low of $3.43 and high of $4.24.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.